ARM and NIIMBL Release Project A-Cell To Bring Quality By Design Principles To Cell-Based Therapy Manufacturing
July 26, 2022 11:08 ET | Alliance For Regenerative Medicine
Washington, DC, July 26, 2022 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) and the National Institute for Innovation in Manufacturing BioPharmaceuticals (NIIMBL) today released...
Alliance for Regenerative Medicine Announces CEO Transition
April 27, 2022 09:00 ET | Alliance For Regenerative Medicine
Washington, DC, April 27, 2022 (GLOBE NEWSWIRE) -- Janet Lynch Lambert will step down as the CEO of the Alliance for Regenerative Medicine after guiding the leading international advocacy...
Cell and Gene Therapies Poised to Disrupt Health Care Status Quo With Wave of New Treatments
March 31, 2022 09:00 ET | Alliance For Regenerative Medicine
Washington, DC, March 31, 2022 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine, the leading international advocacy organization dedicated to realizing the promise of regenerative...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Announces Election of 2022 Officers, Executive Committee, and Board of Directors
October 21, 2021 09:00 ET | Alliance for Regenerative Medicine
Washington, DC, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise...
Alliance Reg Med.png
Global Cell & Gene Therapy Sector on Pace for Annual Records in Product Approvals and Financings, Says Alliance for Regenerative Medicine
August 18, 2021 09:42 ET | Alliance for Regenerative Medicine
ARM’s H1 2021 Report Chronicles ‘A Year of Firsts’ For The Regenerative Medicine Sector Washington, DC, Aug. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The regenerative medicine and...
Alliance Reg Med.png
Alliance for Regenerative Medicine Annual Report Highlights Record Sector Growth and Resilience in 2020
March 16, 2021 10:43 ET | Alliance for Regenerative Medicine
Sector financing reached $19.9B in 2020, doubling from the previous year; 2021 is likely to be a record year for the number of regulatory decisions on new regenerative medicine products Washington,...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Announces Record Sector Financing in 2020
November 19, 2020 09:17 ET | Alliance for Regenerative Medicine
The regenerative medicine sector attracted $15.9 billion in financing through just the first three quarters of the year, shattering the previous record of $13.5 billion Washington, DC, Nov. 19, 2020...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Announces Election of 2021 Officers, Executive Committee, and Board of Directors
October 21, 2020 12:18 ET | Alliance for Regenerative Medicine
Washington, DC, Oct. 21, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization dedicated to realizing the promise...
Alliance Reg Med.png
ARM and NAMCP Publish Recommendations to Increase Patient Access in Joint Study, Roadmap for Navigating the Provider Side of Cell and Gene Therapy (CGT) Patient Access in US Managed Care
October 12, 2020 09:33 ET | Alliance for Regenerative Medicine
Washington, DC, Oct. 12, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire-- Reducing payment and reimbursement barriers is the most important factor in driving provider uptake of cell and gene therapies,...
Alliance Reg Med.png
New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19
August 06, 2020 09:00 ET | Alliance for Regenerative Medicine
Cell, Gene & Tissue-Based Therapy Developers Poised to Break Year-Over-Year Global Financing Records WASHINGTON, D.C., Aug. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --The Alliance...